SPEAKERS

ALL SPEAKERS

Scott Biggs

Director, Supplier Services

IQVIA

Bob Hoffman

Bob Hoffman

AAM Board Chair

Alex Keeton

Alex Keeton

Executive Director of the Biosimilars Council

Senior Vice President, Policy, AAM

Iilun Murphy, M.D.

Iilun Murphy, M.D.

Director

Office of Generic Drugs (OGD), CDER FDA

John Murphy III

John Murphy III

President and CEO

AAM

Giuseppe Randazzo, M.S.

Giuseppe Randazzo, M.S.

Senior Vice President, Sciences and Regulatory Affairs

AAM

Sarah Yim, M.D.

Sarah Yim, M.D.

Director, Office of Therapeutic Biologics and Biosimilars, Office of New Drugs, CDER

FDA